TY  - GEN
AU  - Losina,E
AU  - Daigle,M E
AU  - Suter,L G
AU  - Hunter,D J
AU  - Solomon,D H
AU  - Walensky,R P
AU  - Jordan,J M
AU  - Burbine,S A
AU  - Paltiel,A D
AU  - Katz,J N
TI  - Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
SN  - 1522-9653
PY  - 2013///1001
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Inflammatory Agents
KW  - adverse effects
KW  - Arthroplasty, Replacement, Knee
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Disease Progression
KW  - Drug Costs
KW  - statistics & numerical data
KW  - Female
KW  - Health Care Costs
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Models, Econometric
KW  - Osteoarthritis, Knee
KW  - complications
KW  - Pain
KW  - etiology
KW  - Quality of Life
KW  - Sensitivity and Specificity
KW  - United States
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/j.joca.2013.01.016
ER  -